High-quality medicines to treat a range of conditions
In response to the changing needs of the people we serve, we continuously develop our range of medicines, with a focus on differentiated products and delivery systems. Currently, we manufacture hundreds of generic medicines in the US.
Quick Links
Consumer Product Safety Improvement Act and CRC products
Related news
Hikma launches generic Advair Diskus® following FDA approval
17 December 2020
Hikma launches Icosapent Ethyl Capsules
5 November 2020